DHG Pharmaceutical

DHG

VN000000DHG0

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. Other stock markets 03:30:00 16/07/2024 am IST			5-day change	1st Jan Change
1,20,500 ^VND	+6.92%		+7.69%	+15.87%

09/07	DHG Pharmaceutical Joint Stock Company Announces Resignation of Vu Thi Huong Lan as Hr Director, Effective from July 15, 2024	CI
09/07	DHG Pharmaceutical Joint Stock Company Announces Resignation of Nhung Thi Hong Le as Finance Director, Effective from July 15, 2024	CI

DHG Pharmaceutical Joint Stock Company Announces Executive Changes

January 23, 2017 at 10:02 pm IST

DHG Pharmaceutical Joint Stock Company approved resignation of Ho Buu Huan as Chief Accountant as from January 19, 2017. The company also announced the appointment of Mr. Jun Kuroda, Ms. Nguyen Ngoc Diep and Ms. Le Thi Hong Nhung.

Latest news about DHG Pharmaceutical

DHG Pharmaceutical Joint Stock Company Announces Resignation of Vu Thi Huong Lan as Hr Director, Effective from July 15, 2024	09/07	CI
DHG Pharmaceutical Joint Stock Company Announces Resignation of Nhung Thi Hong Le as Finance Director, Effective from July 15, 2024	09/07	CI
DHG Pharmaceutical Joint Stock Company Announces Resignation of Doan Dinh Duy Khuong from Position of BOD Member and Chief Operating Officer	01/07	CI
DHG Pharmaceutical Joint Stock Company Announces First and Second Cash Dividends for the Year 2023, Payable on June 26, 2024 and August 21, 2024 Respectively	30/05	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024	19/04	CI
DHG Pharmaceutical Joint Stock Company Announces Resignation of Marketing Director Tran Duy Hung	28/03	CI
DHG Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2024	19/01	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	19/01	CI
DHG Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2024	02/01	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	21/23/21	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	20/23/20	CI
DHG Pharmaceutical Joint Stock Company Announces Change in Personnel	21/23/21	CI
DHG Pharmaceutical Joint Stock Company Approves Cash Dividend for the Year 2022, Payable on May 12, 2023	21/23/21	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023	20/23/20	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023	20/23/20	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	19/23/19	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2022	19/23/19	CI
DHG Pharmaceutical Joint Stock Company Approves Executive Changes	05/22/05	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	18/22/18	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	20/22/20	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022	20/22/20	CI
DHG Pharmaceutical Joint Stock Company Announces Cash Dividend for the for 2021, Payable on April 15, 2022	25/22/25	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	20/22/20	CI
DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	20/21/20	CI
Dhg Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter Ended June 30, 2021	20/21/20	CI

Chart DHG Pharmaceutical

Duration

Period

More charts

Company Profile

DHG Pharmaceutical Joint Stock Company is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures and markets pharmaceutical products, vitamins, supplements and cosmetics. Via its subsidiaries, the Company is also involved in packaging printing, herb cultivation, medicinal supplies trading, as well as domestic travel tour and medical clinic operation.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Ratings for DHG Pharmaceutical

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

1,12,700 VND

Average target price

1,16,593 VND

Spread / Average Target

+3.45%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
DHG PHARMACEUTICAL	+15.87%	58Cr
ELI LILLY AND COMPANY	+63.41%	86TCr
NOVO NORDISK A/S	+38.95%	63TCr
JOHNSON & JOHNSON	-4.20%	36TCr
MERCK & CO., INC.	+17.56%	32TCr
ABBVIE INC.	+8.61%	30TCr
ROCHE HOLDING AG	+6.05%	23TCr
NOVARTIS AG	+16.57%	23TCr
AMGEN INC.	+15.51%	18TCr
PFIZER, INC.	+1.99%	16TCr

Other Pharmaceuticals